Clinical and immunological worsening in a patient affected with Waldenstrom macroglobulinemia and anti-mag neuropathy after treatment with rituximab

Haematologica. 2006 Jun;91(6 Suppl):ECR17.

Authors

Maira Gironi¹, M Saresella, L Ceresa, M Calvo, P Ferrante, F Merli, R Nemni

Affiliation

¹ Neurology Department, IRCCS Don C. Gnocchi Foundation, Milano, Italy. mgironi@dongnocchi.it

PMID: 16785123

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal / adverse effects*
Antibodies, Monoclonal, Murine-Derived
Antigens, CD / blood
CD4 Antigens / blood
CD8 Antigens / blood
Disease Progression
Female
Humans
Immunologic Factors / adverse effects
Lipopolysaccharide Receptors / blood
Middle Aged
Nervous System Diseases / complications
Nervous System Diseases / immunology
Rituximab
Waldenstrom Macroglobulinemia / complications
Waldenstrom Macroglobulinemia / drug therapy*

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Antigens, CD
CD4 Antigens
CD8 Antigens
Immunologic Factors
Lipopolysaccharide Receptors
Rituximab